Insider · CIK 0001898606
Adah Almutairi
Files at IVCB (Investcorp Europe Acquisition Corp I). First filing -, latest -.
In brief
Adah Almutairi files SEC Form 4 as director at IVCB (Investcorp Europe Acquisition Corp I). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Adah Almutairi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | IVCB Investcorp Europe Acquisition Corp I | SOpen-market sale Class A ordinary shares | -25,200 | - | - | 10,800 | Dec 27, 2024 |
| Jan 2, 2024 | IVCB Investcorp Europe Acquisition Corp I | MOption exercise Class A ordinary shares | +36,000 | - | - | 36,000 | Jan 22, 2024 |
| Jan 2, 2024 | IVCB Investcorp Europe Acquisition Corp I | MOption exercise Class B ordinary sharesderivative | -36,000 | - | - | 0 | Jan 22, 2024 |
Questions about Adah Almutairi
Answered from the filings on this page, as of the latest one.
Is Adah Almutairi buying or selling?
Adah Almutairi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Adah Almutairi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adah Almutairi has 0.
Where does Adah Almutairi file Form 4?
Adah Almutairi has filed Form 4 at IVCB (Investcorp Europe Acquisition Corp I). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.